Carlsmed announced a 58% year-over-year revenue increase to $16.1 million in Q1 2026, driven by strong sales of its AI-enabled personalized spine surgery products. The company highlighted clinical data showing a 74% reduction in revision surgeries with its aprevo® implants, supporting its market differentiation. Carlsmed also launched new products including the corra™ cervical plating system and expanded its lumbar platform. It raised its full-year 2026 revenue guidance to $72-$77 million, expecting continued growth and innovation.
Occidental Petroleum changed its capital strategy in 2023 from reducing debt to redeeming preferred stock, influenced by fluctuating commodity prices. This shift may continue into 2024, affecting the company's balance sheet and cost of capital. Inves...
Figma has been upgraded to a buy rating following a strong first quarter where it reported 43% year-over-year revenue growth and raised its revenue outlook to over $1.4 billion for the year. The company continues to show robust customer retention nea...
Yanik Guillemette, a Canadian tech entrepreneur, criticizes Ottawa's increasing digital regulations, including a proposed 15% revenue tax on streaming platforms and laws C-11, C-18, and C-22. He argues these measures burden the tech ecosystem, raise ...
Yanik Guillemette, a Montreal-based entrepreneur and investment strategist, criticizes Canada's growing digital regulations, including the CRTC's proposal for streaming platforms to fund Canadian content. He argues these rules increase costs for cons...
Intuitive Machines is transitioning from focusing solely on lunar landers to becoming a broader space infrastructure platform, with revenue expected to reach $210 million in 2025. Despite rapid revenue growth, the company continues to face persistent...
